ABSTRACT

Conclusion:

Although studies demonstrated that optimal cytoreductive surgery provides longer survival in ovarian cancer patients, patient’s medical and physical conditions like age, systemic illness, chemotherapy history are also important for morbidity and mortality.

Results:

Rectosigmoid tumor extirpation and primer anastomosis (n=1), colostomy (n=1), appendectomy (n=3), tumor extirpation from sigmoid mesentery (n=5), tumor extirpation from transvers colon mesentery (n=1) and rectovaginal tumor extirpation (n=1) was performed. In three of the patients the dissection of adhesions was performed without any damage to colon with the aim of optimal cytoreduction. Serious hemorrage occured in one patient due to use of anticoagulation drugs at the fourth postoperative day.

Methods:

We reviewed 120 patients who underwent gynecologic oncology operations between 2008-2009 in Ege University Hospital. Colon surgery was performed 14 of them.(%11.6) The mean age of patients who had colon surgery were 58.2(37-77). Two patients underwent surgery besides ovarian carcinoma; one of them with the diagnosis of endometrium adenocarcinoma and the other with primary tubal adenocarcinoma. All the others were (n=12) operated with the diagnosis of ovarian carcinoma.

Objective:

To discuss the benefits, morbidity and mortality and the endications for colon resection in gynecologic oncology especially in cytoreductive ovarian cancer operations and to present a case series.